Age (years) | Number of subjects | eGFR | Number of subjects with reduced eGFR | % | Proteinuria | |||||
---|---|---|---|---|---|---|---|---|---|---|
Mean ± SD | (−) | % | (±) | % | (+≤) | % | ||||
Men | ||||||||||
20–29 | 714 | 99.8 ± 16.9 | 0 | 0.0 | 648 | 90.7 | 47 | 6.6 | 19 | 2.7 |
30–39 | 850 | 89.8 ± 16.3a | 11 | 1.3 | 766 | 90.1 | 54 | 6.5 | 30 | 3.5 |
40–49 | 724 | 81.9 ± 15.3a,b | 45 | 6.2 | 645 | 89.1 | 54 | 7.5 | 25 | 3.5 |
50–59 | 633 | 77.9 ± 16.1a,b,c | 63 | 10.0 | 570 | 90.0 | 31 | 4.9 | 32 | 5.1 |
60–69 | 441 | 73.1 ± 15.8a,b,c,d | 102 | 23.1 | 393 | 89.1 | 25 | 5.7 | 23 | 5.2 |
70–79 | 105 | 68.1 ± 14.5a,b,c,d | 32 | 30.5 | 89 | 84.7 | 5 | 4.8 | 11 | 10.5 |
Total | 3467 | 85.3 ± 18.6 | 253 | 7.3 | 3111 | 89.7 | 216 | 6.2 | 140 | 4.0 |
Women | ||||||||||
20–29 | 1832 | 106.7 ± 21.9 | 10 | 0.5 | 1697 | 92.6 | 101 | 5.5 | 34 | 1.9 |
30–39 | 1703 | 96.8 ± 20.3a | 29 | 1.7 | 1608 | 94.4 | 70 | 4.1 | 25 | 1.5 |
40–49 | 1483 | 87.6 ± 19.0a,b | 66 | 4.5 | 1396 | 94.1 | 60 | 4.0 | 27 | 1.8 |
50–59 | 1459 | 81.2 ± 18.7a,b,c | 141 | 9.7 | 1386 | 95.0 | 51 | 3.5 | 22 | 1.5 |
60–69 | 921 | 75.5 ± 16.4a,b,cd | 133 | 14.4 | 875 | 95.0 | 28 | 3.0 | 18 | 2.0 |
70–79 | 165 | 70.8 ± 16.3a,b,c,d | 38 | 23.0 | 155 | 93.9 | 6 | 3.6 | 4 | 2.4 |
Total | 7563 | 91.2 ± 22.6 | 417 | 5.5 | 7117 | 94.1 | 316 | 4.2 | 130 | 1.7 |